KRT33B
gene geneOn this page
Also known as Ha-3II
Summary
KRT33B (keratin 33B, HGNC:6451) is a protein-coding gene on chromosome 17q21.2, encoding Keratin, type I cuticular Ha3-II (Q14525).
This gene encodes a member of the keratin gene family. This gene is one of multiple type I hair keratin genes that are clustered in a region of chromosome 17q12-q21 and have the same direction of transcription. As a type I hair keratin, the encoded protein is an acidic protein which heterodimerizes with type II keratins to form hair and nails. There are two isoforms of this protein, encoded by two separate genes, keratin 33A and keratin 33B.
Source: NCBI Gene 3884 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 85 total
- MANE Select transcript:
NM_002279
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:6451 |
| Approved symbol | KRT33B |
| Name | keratin 33B |
| Location | 17q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Ha-3II |
| Ensembl gene | ENSG00000131738 |
| Ensembl biotype | protein_coding |
| OMIM | 602762 |
| Entrez | 3884 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000251646
RefSeq mRNA: 1 — MANE Select: NM_002279
NM_002279
CCDS: CCDS11389
Canonical transcript exons
ENST00000251646 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001810585 | 41363498 | 41363953 |
| ENSE00002438381 | 41369403 | 41369813 |
| ENSE00002458105 | 41365175 | 41365300 |
| ENSE00002486034 | 41367908 | 41367990 |
| ENSE00002491252 | 41364779 | 41364999 |
| ENSE00002517762 | 41365392 | 41365553 |
| ENSE00002528182 | 41366470 | 41366626 |
Expression profiles
Bgee: expression breadth broad, 59 present calls, max score 48.94.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0502 / max 12.5852, expressed in 29 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 165889 | 0.0502 | 29 |
Top tissues by expression
112 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| prefrontal cortex | UBERON:0000451 | 48.94 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 46.85 | gold quality |
| frontal cortex | UBERON:0001870 | 44.13 | gold quality |
| sural nerve | UBERON:0015488 | 43.13 | gold quality |
| skin of abdomen | UBERON:0001416 | 42.69 | gold quality |
| zone of skin | UBERON:0000014 | 42.18 | gold quality |
| skin of leg | UBERON:0001511 | 42.05 | gold quality |
| cerebral cortex | UBERON:0000956 | 41.81 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 40.95 | gold quality |
| cortical plate | UBERON:0005343 | 40.23 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 39.94 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 39.39 | gold quality |
| right lung | UBERON:0002167 | 38.95 | gold quality |
| esophagus mucosa | UBERON:0002469 | 37.40 | silver quality |
| right frontal lobe | UBERON:0002810 | 37.23 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| vagina | UBERON:0000996 | 37.20 | gold quality |
| cerebellum | UBERON:0002037 | 36.95 | gold quality |
| cerebellar cortex | UBERON:0002129 | 36.94 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 36.74 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 36.71 | gold quality |
| Ammon’s horn | UBERON:0001954 | 36.37 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 35.62 | gold quality |
| granulocyte | CL:0000094 | 35.60 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| brain | UBERON:0000955 | 33.62 | gold quality |
| minor salivary gland | UBERON:0001830 | 33.41 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 33.03 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.18 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
15 targeting KRT33B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-548M | 99.70 | 68.87 | 1749 |
| HSA-MIR-1251-3P | 99.64 | 67.21 | 1408 |
| HSA-MIR-561-3P | 99.64 | 70.90 | 3647 |
| HSA-MIR-7156-5P | 99.64 | 68.81 | 1369 |
| HSA-MIR-6852-5P | 99.17 | 66.69 | 2073 |
| HSA-MIR-3125 | 99.14 | 68.49 | 2269 |
| HSA-MIR-3916 | 98.99 | 68.04 | 2155 |
| HSA-MIR-6859-5P | 98.99 | 68.07 | 2049 |
| HSA-MIR-450A-2-3P | 97.91 | 67.56 | 1459 |
| HSA-MIR-410-5P | 96.55 | 66.28 | 459 |
| HSA-MIR-591 | 96.29 | 68.16 | 611 |
| HSA-MIR-323B-5P | 96.12 | 66.39 | 472 |
| HSA-MIR-494-5P | 95.31 | 66.29 | 463 |
Cross-species orthologs
0 orthologs
Paralogs (68): KRT33A (ENSG00000006059), VIM (ENSG00000026025), KRT31 (ENSG00000094796), NEFM (ENSG00000104722), KRT23 (ENSG00000108244), KRT37 (ENSG00000108417), KRT32 (ENSG00000108759), KRT18 (ENSG00000111057), LMNB1 (ENSG00000113368), KRT36 (ENSG00000126337), KRT17 (ENSG00000128422), GFAP (ENSG00000131095), KRT34 (ENSG00000131737), NES (ENSG00000132688), PRPH (ENSG00000135406), KRT85 (ENSG00000135443), KRT7 (ENSG00000135480), KRT71 (ENSG00000139648), INA (ENSG00000148798), LMNTD1 (ENSG00000152936), LMNA (ENSG00000160789), KRT84 (ENSG00000161849), KRT82 (ENSG00000161850), KRT80 (ENSG00000167767), KRT1 (ENSG00000167768), KRT24 (ENSG00000167916), KRT8 (ENSG00000170421), KRT78 (ENSG00000170423), KRT86 (ENSG00000170442), KRT75 (ENSG00000170454), KRT6C (ENSG00000170465), KRT4 (ENSG00000170477), KRT74 (ENSG00000170484), KRT72 (ENSG00000170486), KRT83 (ENSG00000170523), BFSP2 (ENSG00000170819), KRT19 (ENSG00000171345), KRT15 (ENSG00000171346), KRT38 (ENSG00000171360), KRT13 (ENSG00000171401)
Protein
Protein identifiers
Keratin, type I cuticular Ha3-II — Q14525 (reviewed: Q14525)
Alternative names: Hair keratin, type I Ha3-II, Keratin-33B
All UniProt accessions (1): Q14525
UniProt curated annotations — full annotation on UniProt →
Miscellaneous. There are two types of hair/microfibrillar keratin, I (acidic) and II (neutral to basic).
Similarity. Belongs to the intermediate filament family.
RefSeq proteins (1): NP_002270* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002957 | Keratin_I | Family |
| IPR018039 | IF_conserved | Conserved_site |
| IPR039008 | IF_rod_dom | Domain |
Pfam: PF00038
UniProt features (11 total): region of interest 7, chain 1, domain 1, sequence conflict 1, site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q14525-F1 | 80.40 | 0.61 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 305 (stutter)
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-6809371 | Formation of the cornified envelope |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 83 (showing top):
GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM, GOBP_EPITHELIUM_DEVELOPMENT, MORF_FLT1, GOBP_INTERMEDIATE_FILAMENT_BASED_PROCESS, GOBP_INTERMEDIATE_FILAMENT_ORGANIZATION, ENK_UV_RESPONSE_KERATINOCYTE_UP, MARTINEZ_RB1_TARGETS_DN, MODULE_298, MODULE_157, GOBP_MOLTING_CYCLE, NRF2_Q4, MORF_ETV3, TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA, GOBP_TISSUE_MORPHOGENESIS, MODULE_104
GO Biological Process (4): morphogenesis of an epithelium (GO:0002009), epithelial cell differentiation (GO:0030855), hair cycle (GO:0042633), intermediate filament organization (GO:0045109)
GO Molecular Function (3): structural constituent of skin epidermis (GO:0030280), structural molecule activity (GO:0005198), protein binding (GO:0005515)
GO Cellular Component (6): obsolete extracellular space (GO:0005615), cytosol (GO:0005829), cytoskeleton (GO:0005856), keratin filament (GO:0045095), extracellular exosome (GO:0070062), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
| Keratinization | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| epithelium development | 2 |
| tissue morphogenesis | 1 |
| cell differentiation | 1 |
| molting cycle | 1 |
| intermediate filament cytoskeleton organization | 1 |
| supramolecular fiber organization | 1 |
| structural molecule activity | 1 |
| molecular_function | 1 |
| binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| intermediate filament | 1 |
| extracellular vesicle | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
684 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRT33B | KRTAP3-1 | Q9BYR8 | 489 |
| KRT33B | KRTAP3-2 | Q9BYR7 | 466 |
| KRT33B | C22orf31 | O95567 | 446 |
| KRT33B | KRTAP3-3 | Q9BYR6 | 434 |
| KRT33B | KRTAP9-3 | Q9BYQ3 | 431 |
| KRT33B | KRTAP13-1 | Q8IUC0 | 411 |
| KRT33B | TEX19 | Q8NA77 | 403 |
| KRT33B | KRTAP9-4 | Q9BYQ2 | 399 |
| KRT33B | TCHH | Q07283 | 394 |
| KRT33B | SECTM1 | Q8WVN6 | 377 |
| KRT33B | KRTAP13-3 | Q3SY46 | 353 |
| KRT33B | ZNF664 | Q8N3J9 | 337 |
| KRT33B | HERC2 | O95714 | 333 |
| KRT33B | KRTAP11-1 | Q8IUC1 | 330 |
| KRT33B | ARL5C | A6NH57 | 316 |
| KRT33B | PRR9 | Q5T870 | 316 |
IntAct
286 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRT4 | KRT33B | psi-mi:“MI:0915”(physical association) | 0.780 |
| KRT33B | KRT79 | psi-mi:“MI:0915”(physical association) | 0.780 |
| KRT79 | KRT33B | psi-mi:“MI:0915”(physical association) | 0.780 |
| KRT33B | KRT4 | psi-mi:“MI:0915”(physical association) | 0.780 |
| KRT1 | KRT33B | psi-mi:“MI:0915”(physical association) | 0.740 |
| HGS | KRT33B | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRT33B | NUP58 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KDM1A | KRT33B | psi-mi:“MI:0915”(physical association) | 0.670 |
| KRT33B | KRT78 | psi-mi:“MI:0915”(physical association) | 0.630 |
| KRT33B | AQP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ABI2 | KRT33B | psi-mi:“MI:0915”(physical association) | 0.560 |
| AQP1 | KRT33B | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT33B | ABI2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT33B | KRT71 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (111): KRT33B (Two-hybrid), KRT33B (Two-hybrid), ABI2 (Two-hybrid), KRT79 (Two-hybrid), KRT33B (Affinity Capture-MS), KRT33B (Two-hybrid), KRT33B (Affinity Capture-MS), KRT33B (Affinity Capture-MS), KRT33B (Affinity Capture-MS), KRT33B (Affinity Capture-MS), KRT33B (Affinity Capture-MS), KRT33B (Two-hybrid), KRT33B (Affinity Capture-MS), KRT33B (Two-hybrid), KRT33B (Two-hybrid)
ESM2 similar proteins: A4FUZ0, A5A6M5, A5A6P3, A6QNX5, A7YWK3, B0LKP1, B1AQ75, E1AB55, O43790, O76009, O76013, P02534, P15241, P19013, P25690, P25691, P78385, P78386, P97861, Q0P5J7, Q14525, Q14532, Q14533, Q148H4, Q148H5, Q148H7, Q148H8, Q14CN4, Q15323, Q3SY84, Q497I4, Q61765, Q61897, Q62168, Q6IG03, Q6IG04, Q6IME9, Q6IMF0, Q6NXH9, Q86Y46
Diamond homologs: A1KQY9, A1L317, A1L595, A5A6M0, A5A6M5, A5A6N2, A5A6P3, A6BLY7, A6QQQ9, A7YWM2, B0LKP1, B1AQ75, O57607, O57611, O76009, O76013, O77727, O93256, P02533, P02534, P02535, P02537, P05781, P05783, P05784, P06394, P08727, P08728, P08730, P08777, P08778, P08779, P08802, P13645, P13646, P19001, P19012, P25030, P25690, P35527
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 72 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Formation of the cornified envelope | 19 | 34.1× | 1e-22 |
| Keratinization | 19 | 21.6× | 5e-19 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| intermediate filament organization | 19 | 66.3× | 8e-28 |
| keratinization | 16 | 54.3× | 8e-22 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
85 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 81 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
542 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:41364777:A:AC | donor_gain | 1.0000 |
| 17:41364778:C:CC | donor_gain | 1.0000 |
| 17:41364995:TATCG:T | acceptor_gain | 1.0000 |
| 17:41364996:ATCG:A | acceptor_gain | 1.0000 |
| 17:41364997:TCG:T | acceptor_gain | 1.0000 |
| 17:41364998:CG:C | acceptor_gain | 1.0000 |
| 17:41364998:CGC:C | acceptor_gain | 1.0000 |
| 17:41365000:C:A | acceptor_loss | 1.0000 |
| 17:41365000:C:CC | acceptor_gain | 1.0000 |
| 17:41365002:G:C | acceptor_gain | 1.0000 |
| 17:41365002:G:GC | acceptor_gain | 1.0000 |
| 17:41365005:G:C | acceptor_gain | 1.0000 |
| 17:41365005:G:GC | acceptor_gain | 1.0000 |
| 17:41365296:TCGGT:T | acceptor_gain | 1.0000 |
| 17:41365297:CGGT:C | acceptor_gain | 1.0000 |
| 17:41365297:CGGTC:C | acceptor_gain | 1.0000 |
| 17:41365298:GGT:G | acceptor_gain | 1.0000 |
| 17:41365298:GGTC:G | acceptor_loss | 1.0000 |
| 17:41365299:GT:G | acceptor_gain | 1.0000 |
| 17:41365299:GTC:G | acceptor_loss | 1.0000 |
| 17:41365300:TCT:T | acceptor_loss | 1.0000 |
| 17:41365301:C:CC | acceptor_gain | 1.0000 |
| 17:41365302:T:A | acceptor_loss | 1.0000 |
| 17:41365307:C:CT | acceptor_gain | 1.0000 |
| 17:41365310:C:CT | acceptor_gain | 1.0000 |
| 17:41365311:C:CT | acceptor_gain | 1.0000 |
| 17:41365311:C:T | acceptor_gain | 1.0000 |
| 17:41365312:A:T | acceptor_gain | 1.0000 |
| 17:41365388:CCACC:C | donor_loss | 1.0000 |
| 17:41365417:T:TA | donor_gain | 1.0000 |
AlphaMissense
2643 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:41369554:C:G | R66P | 0.997 |
| 17:41364890:C:G | R329P | 0.992 |
| 17:41365194:A:G | L286P | 0.992 |
| 17:41369551:A:G | L67P | 0.992 |
| 17:41364818:A:G | I353T | 0.991 |
| 17:41364902:A:G | L325P | 0.991 |
| 17:41364830:A:G | L349P | 0.990 |
| 17:41369521:A:G | L77P | 0.990 |
| 17:41364800:A:G | L359P | 0.988 |
| 17:41364818:A:C | I353S | 0.988 |
| 17:41364881:A:G | L332P | 0.988 |
| 17:41369413:A:G | L113P | 0.988 |
| 17:41369549:C:G | A68P | 0.988 |
| 17:41365189:C:G | A288P | 0.987 |
| 17:41369555:G:T | R66S | 0.987 |
| 17:41369563:A:G | L63P | 0.987 |
| 17:41364851:A:G | L342P | 0.986 |
| 17:41364872:T:G | Q335P | 0.986 |
| 17:41364977:A:G | L300P | 0.986 |
| 17:41369539:A:G | L71P | 0.986 |
| 17:41369551:A:T | L67Q | 0.986 |
| 17:41364806:C:G | R357P | 0.985 |
| 17:41364944:A:G | L311P | 0.985 |
| 17:41367939:C:G | A134P | 0.985 |
| 17:41364810:A:C | Y356D | 0.984 |
| 17:41364821:T:A | E352V | 0.983 |
| 17:41364875:C:G | R334P | 0.983 |
| 17:41365227:A:G | L275P | 0.983 |
| 17:41369500:A:G | L84P | 0.983 |
| 17:41369560:T:A | N64I | 0.983 |
dbSNP variants (sampled 300 via entrez): RS1001513582 (17:41364885 C>T), RS1001533348 (17:41370098 C>T), RS1001534485 (17:41371770 A>G), RS1001546133 (17:41365070 C>G,T), RS1001847099 (17:41366085 T>C), RS1002279077 (17:41369172 T>C), RS1003282446 (17:41370434 C>A,G), RS1003524738 (17:41367682 T>A,C), RS1003555947 (17:41367945 C>T), RS1003972730 (17:41366034 C>T), RS1004305164 (17:41370386 A>T), RS1004491286 (17:41366524 G>C,T), RS1005084450 (17:41364119 A>G), RS1005103621 (17:41370673 A>G), RS1005609430 (17:41367387 A>G)
Disease associations
OMIM: gene MIM:602762 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 2-methyl-4-isothiazolin-3-one | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| potassium chromate(VI) | increases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Estradiol | affects binding, increases reaction | 1 |
| Folic Acid | decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Smoke | increases expression | 1 |
| 1-Methyl-4-phenylpyridinium | increases expression | 1 |
| Asbestos, Crocidolite | increases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Particulate Matter | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.